This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

HMO To Stand Trial In Las Vegas For Role In Largest Hepatitis C Outbreak In U.S. History

LAS VEGAS , Feb. 19, 2013 /PRNewswire/ -- Health Plan of Nevada will face a Nevada jury for the role of the HMO in the largest outbreak of hepatitis C in U.S. history.

(Photo: http://photos.prnewswire.com/prnh/20130219/LA62190)

The complaint filed in Clark County District Court cites the duty to monitor the effectiveness and safety of the health care providers and clinics required by the HMO for use by its members, and the failure to monitor, as leading to the notification from the Southern Nevada Health District to 50,000 Nevadans that they may have been exposed to hepatitis C or HIV. The complaint also cites billing fraud, changing of records to conceal malpractice and false advertising. 

"The Health Plan of Nevada can not take money from thousands of Nevadans, require them to use clinics such as the Endoscopy Center of Southern Nevada and not look out for their safety. This and other facts about what the HMO knew about the practices of Dr. Desai and the clinics will be exposed in trial," said Robert Eglet, lead trial attorney for the plaintiffs. 

Bonnie Brunson, one of the genetically linked patients identified by the CDC and the Southern Nevada Health District, and husband Carl Brunson, and Helen Meyer, an individual, are named as plaintiffs. 

Opening statements begin February 20, 9am, Regional Justice Center, 200 Lewis Avenue, Las Vegas, 89101 in Department 12D before Judge Timothy Williams. Follow trial updates on twitter: @LVHepCTrial. 







SOURCE SCM

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,493.37 -69.93 -0.42%
S&P 500 1,925.15 -5.52 -0.29%
NASDAQ 4,352.6390 -17.1340 -0.39%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs